Scroll to the bottom to watch the entire 20 mins explainer
Overview:
FDA’s
Quality Management System Regulation (QMSR) is now in effect, and medical
device companies are beginning to face the practical inspection realities that
come with the shift from QSR to QMSR. This free webinar explains what quality,
regulatory, supplier, CAPA, complaint, UDI, labeling, and manufacturing teams
should understand as early QMSR inspection activity begins to reveal practical
readiness signals.
The
session focuses on how medical device companies can prepare before an FDA
investigator arrives. It is not just about updating procedures or aligning
documents with ISO 13485:2016. The bigger question is whether the company can
show that its quality system is working in daily operations.
The quick webinar walks through practical inspection themes involving risk management,
supplier controls, complaint handling, MDR evaluation, UDI and traceability,
CAPA, internal audits, management review, and quality culture. It also explains
why QMSR readiness should be treated as a cross-functional responsibility, not
something owned only by QA or regulatory affairs.
Areas Covered:
- What
changed from QSR to QMSR
- Why
QMSR is more than a paperwork update
- How
QMSR aligns FDA medical device quality requirements with ISO 13485:2016
- Why
early Form 483 observations should be treated as inspection signals
- What
FDA investigators may expect to see during QMSR inspections
- How
risk management should connect across the quality system
- Supplier
control expectations for outsourced activities
- Why
companies can outsource work but not quality responsibility
- Complaint
handling as regulatory and post-market quality data
- How
complaint files should connect to MDR, CAPA, risk review, and trend analysis
- UDI
and traceability expectations for complaints, investigations, and recall
readiness
- CAPA
expectations around root cause, corrective action, and effectiveness checks
- Internal
audit and management review record readiness
- Why
audit findings should be factual, specific, and evidence-based
- Common
documentation mistakes that can create inspection risk
- Quality
culture and cross-functional escalation
- Practical
readiness questions for QA, regulatory affairs, supplier quality, complaint
handling, CAPA owners, manufacturing, and leadership
Why
Should You Watch This Webinar?
QMSR
is already in effect, which means medical device companies should move beyond
general awareness and begin checking whether their quality system can stand up
during a real inspection. A procedure may exist, but FDA investigators may look
for evidence that the process is being used, connected, reviewed, and improved
in actual operations.
This
webinar helps quality and regulatory teams understand where inspection pressure
may appear first: risk files, supplier files, complaint records, MDR
evaluations, UDI capture, CAPA records, internal audit reports, and management
review documentation. These are areas where weak documentation can make a
company look unprepared even when the underlying process exists.
The
practical value of this video is that it turns QMSR readiness into a working
checklist. Viewers will understand what different teams should review, what
records should explain clearly, and how to connect quality system evidence
before inspection findings become harder to manage.
Who
Will Benefit?
This
video is designed for medical device professionals involved in quality system
readiness, inspection preparation, product risk, supplier oversight, complaint
handling, corrective action, regulatory reporting, labeling, traceability, and
management review. Those include:
- Quality
Assurance Managers/Quality Systems Managers
- Regulatory
Affairs Managers/Regulatory Affairs Specialists
- Supplier
Quality Managers/Supplier Quality Engineers
- CAPA
Owners/Complaint Handling Teams
- Post-Market
Surveillance Teams/MDR Reporting Teams
- UDI
and Labeling Teams/Manufacturing Quality Managers
- Quality
Engineers/Design Quality Engineers
- Operations
Managers/Production Managers
- Internal
Audit Teams/Management Review Coordinators
- Compliance
Officers/Medical Device Executives
- Quality
Directors/Regulatory Directors
- Inspection Readiness Teams/Medical Device Consultants
- ISO 13485 Compliance Professionals
Watch the entire 20 mins explainer here:
This
webinar is presented by Amorit Education’s in-house experts, who closely
monitor FDA regulatory, compliance, quality system, and industry developments
affecting medical device, pharmaceutical, biotechnology, and other life
sciences organizations. Their work is focused on turning complex FDA and
regulatory updates into practical guidance that helps quality, regulatory,
compliance, operations, and business teams understand what has changed, why it
matters, where risks may emerge, and what actions may deserve closer attention.
For
this session, the focus is on helping medical device professionals understand
the practical impact of QMSR, including how quality systems, risk management,
supplier oversight, complaint handling, CAPA, UDI, internal audits, and
management review may need to work together under current FDA expectations.

